Diagnostic Imaging Market Regional Analysis

Why is North America Leading Diagnostic Imaging Market in 2024?

As per the 2024, the North American diagnostic imaging market share is predicted to hold the largest share among all regions in 2024. The high spending the region observes on healthcare along with factors such as rapid adoption of digital technologies in healthcare by people in the region and advanced medical infrastructure all contribute to its growth. The rising prevalence of chronic diseases and demand for early diagnosis also continue to spur adoption in the region. The US emerges as the hub for diagnostic imaging manufacture and sales in the region.

U.S. Diagnostic Imaging Market

In North America, U.S. leads the diagnostic imaging market share especially due to its advanced healthcare infrastructure, strong demand among public for early diagnosis, and high adoption of modern technologies. Many key players in the market such as GE Healthcare, Hologic Inc., etc. are headquartered here. The presence of these major industry players and increased R&D funding creates an environment for innovation in various diagnostic imaging products. In 2025, a few researchers developed a breakthrough 3D medical imaging technology using photon counting detectors and novel algorithms at the University of Houston. This innovation provides a faster, more precise, and cost-effective alternative to traditional X-rays and MRIs. This shows the positive environment in the US for innovation in the diagnostic imaging industry.

Canada Diagnostic Imaging Market

Canada in North America is just behind the U.S. The country’s diagnostic imaging market’s growth can be credited to public healthcare funding, national imaging guidelines, and growing investments in digital health infrastructure. Collaborations between the provincial government and key companies are also encouraging market growth. In March 2025, The Government of Alberta and Siemens Healthineers came together to launch an $560 million USD and eight-year long initiative. This will focus on upgrading aging cancer diagnostic imaging equipment with AI-enabled systems. The partnership envisions that oncology-related emergency visits will be cut by 30% and treatment wait times will be reduced by 50% as an outcome.

Why is Demand for Diagnostic Imaging Fueling Growth in Asia Pacific?

Asia-Pacific is predicted to grow at the highest rate in the diagnostic imaging market growth over the projection period of 2025-2032. The growth in the region is led by the rising aging population and prevalence of chronic diseases among people in this region. Other factors such as expanding healthcare access, and investments in medical technology also support greater growth of diagnostic imaging. China, India, and Japan serve as major hubs. All of these factors contribute to the fast rate at which the diagnostic imaging market of Asia Pacific is growing.

China Diagnostic Imaging Market

The China diagnostic imaging market expansion can be credited to various reasons. This expansion can be because of its vast population, growing middle class, and rising prevalence of chronic diseases. Government support in the form of regulatory approvals is also a huge reason behind the market’s progress. In June 2025, ZEISS Medical Technology received NMPA approval in China for its CLARUS 700. This system provides ultra-widefield, high-resolution True Color retinal imaging with integrated fluorescein angiography. It improves the diagnostic precision and efficiency of workflow for retinal specialists.

Japan Diagnostic Imaging Market

Japan’s diagnostic imaging market growth is spurred by its well-established healthcare system, aging population, high standards in healthcare, and adoption of medical technology at an early stage. Strong regulatory support, local innovation from companies like Fujifilm Corporation, Canon Inc., etc. have also played huge roles in positioning Japan as an influential market for diagnostic imaging. In 2023, Canon Inc., Canon Medical, and Japan’s National Cancer Center started clinical research using Japan’s first domestically produced photon-counting CT (PCCT) system. Advanced imaging technology promises valuable breakthroughs in cancer diagnostics and treatment.

How is Europe Maintaining its Position in the Diagnostic Imaging Industry?

Europe held a significant diagnostic imaging market share in 2024 and is likely to continue so during the forecast period of 2025-2032. This can be due to strong regulatory standards, an increase in adoption of digital imaging, and emphasis on early disease detection in the region. Countries in Europe are focusing on upgrading their diagnostic infrastructure and expanding access to modern imaging technologies. Collaborations between research institutes and companies create room for innovation in modalities like MRI, CT, and PET imaging.

Germany Diagnostic Imaging Market

Germany has the one of the largest European markets for diagnostic imaging. Its growth is supported by its strong healthcare infrastructure and digital transformation initiatives. The country’s focus on research and precision medicine has also encouraged adoption. It witnesses high demand for MRI and CT scans. Integration of AI and teleradiology is improving diagnostic efficiency, while government support ensures accessibility and continuous modernization of diagnostic imaging infrastructure. Major medical device manufacturers such as Siemens Healthineers, SternMed GmbH, etc. are located here.

France Diagnostic Imaging Market

The France diagnostic imaging market share is also experiencing steady growth. The market benefits from its national focus on preventive care, aging demographics, and public investments in digital health infrastructure. Increasing use of advanced modalities such as PET-CT and digital radiography has been witnessed in the country. This makes the French diagnostic imaging market a highly opportune market in upcoming years.

UK Diagnostic Imaging Market

The UK diagnostic imaging market also emerges as a prominent market in the European region. Demand for imaging services is rising in the UK due to chronic disease prevalence and an aging population. Investment in AI technology, mobile diagnostic imaging, and teleradiology is helping to address radiologist shortages. Initiatives to streamline diagnostic pathways in the country are also playing critical roles in the market’s steady growth.